Cargando…
Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
Background and objectives Microalbuminuria is an early sign of diabetic nephropathy (DN). However, pathological abnormalities occur before the onset of microalbuminuria. Renal impairment progresses in about 50% of cases in type 2 diabetes mellitus (T2DM) without significant albuminuria. Diabetes mel...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085351/ https://www.ncbi.nlm.nih.gov/pubmed/37051007 http://dx.doi.org/10.7759/cureus.36011 |
_version_ | 1785021921289568256 |
---|---|
author | Sonkar, Satyendra K Gupta, Akash Sonkar, Gyanendra K Usman, Kauser Bhosale, Vivek Kumar, Satish Sharma, Sharad |
author_facet | Sonkar, Satyendra K Gupta, Akash Sonkar, Gyanendra K Usman, Kauser Bhosale, Vivek Kumar, Satish Sharma, Sharad |
author_sort | Sonkar, Satyendra K |
collection | PubMed |
description | Background and objectives Microalbuminuria is an early sign of diabetic nephropathy (DN). However, pathological abnormalities occur before the onset of microalbuminuria. Renal impairment progresses in about 50% of cases in type 2 diabetes mellitus (T2DM) without significant albuminuria. Diabetes mellitus (DM) is linked with obesity, metabolic syndrome, and lifestyle changes, where adipokines play an important role. Zinc alpha 2 glycoprotein (ZAGP) is an adipokine, and in this study, it was assessed as a potential biomarker for early DN as well as its progression. Materials and methods This study was a cross-sectional case-control study conducted at a tertiary hospital in northern India. T2DM patients aged 18-65 years old were included in the study and were divided into four groups based on their albuminuria level. This study included 160 participants, with 40 participants in each group. Group I included healthy volunteers, while Groups II, III, and IV were normoalbuminuric, microalbuminuric, and macroalbuminuric diabetic patients, respectively. The groups were evaluated for demographic variables, biochemical parameters, urine albumin-creatinine ratio (UACR), and serum ZAGP. Data between the groups were compared statistically. Results This study included 160 participants, with 40 participants in each group. There was a significant difference between the groups based on the serum ZAGP (p<0.001). Serum ZAGP was significantly negatively correlated with serum creatinine, glycosylated hemoglobin (HbA1c), serum cholesterol, serum triglyceride, low-density lipoprotein (LDL) cholesterol, and UACR. ZAGP was positively correlated with the estimated glomerular filtration rate (eGFR). Conclusion The present study showed that ZAGP was an early biomarker of diabetic nephropathy, and its value decreased as DN progressed. It also suggested that ZAGP, an adipokine, has an anti-inflammatory mechanism of action and its depletion worsens the disease. |
format | Online Article Text |
id | pubmed-10085351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-100853512023-04-11 Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients Sonkar, Satyendra K Gupta, Akash Sonkar, Gyanendra K Usman, Kauser Bhosale, Vivek Kumar, Satish Sharma, Sharad Cureus Endocrinology/Diabetes/Metabolism Background and objectives Microalbuminuria is an early sign of diabetic nephropathy (DN). However, pathological abnormalities occur before the onset of microalbuminuria. Renal impairment progresses in about 50% of cases in type 2 diabetes mellitus (T2DM) without significant albuminuria. Diabetes mellitus (DM) is linked with obesity, metabolic syndrome, and lifestyle changes, where adipokines play an important role. Zinc alpha 2 glycoprotein (ZAGP) is an adipokine, and in this study, it was assessed as a potential biomarker for early DN as well as its progression. Materials and methods This study was a cross-sectional case-control study conducted at a tertiary hospital in northern India. T2DM patients aged 18-65 years old were included in the study and were divided into four groups based on their albuminuria level. This study included 160 participants, with 40 participants in each group. Group I included healthy volunteers, while Groups II, III, and IV were normoalbuminuric, microalbuminuric, and macroalbuminuric diabetic patients, respectively. The groups were evaluated for demographic variables, biochemical parameters, urine albumin-creatinine ratio (UACR), and serum ZAGP. Data between the groups were compared statistically. Results This study included 160 participants, with 40 participants in each group. There was a significant difference between the groups based on the serum ZAGP (p<0.001). Serum ZAGP was significantly negatively correlated with serum creatinine, glycosylated hemoglobin (HbA1c), serum cholesterol, serum triglyceride, low-density lipoprotein (LDL) cholesterol, and UACR. ZAGP was positively correlated with the estimated glomerular filtration rate (eGFR). Conclusion The present study showed that ZAGP was an early biomarker of diabetic nephropathy, and its value decreased as DN progressed. It also suggested that ZAGP, an adipokine, has an anti-inflammatory mechanism of action and its depletion worsens the disease. Cureus 2023-03-11 /pmc/articles/PMC10085351/ /pubmed/37051007 http://dx.doi.org/10.7759/cureus.36011 Text en Copyright © 2023, Sonkar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Sonkar, Satyendra K Gupta, Akash Sonkar, Gyanendra K Usman, Kauser Bhosale, Vivek Kumar, Satish Sharma, Sharad Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients |
title | Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients |
title_full | Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients |
title_fullStr | Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients |
title_full_unstemmed | Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients |
title_short | Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients |
title_sort | zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in type 2 diabetes mellitus patients |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085351/ https://www.ncbi.nlm.nih.gov/pubmed/37051007 http://dx.doi.org/10.7759/cureus.36011 |
work_keys_str_mv | AT sonkarsatyendrak zincalpha2glycoproteinasanearlybiomarkerofdiabeticnephropathyintype2diabetesmellituspatients AT guptaakash zincalpha2glycoproteinasanearlybiomarkerofdiabeticnephropathyintype2diabetesmellituspatients AT sonkargyanendrak zincalpha2glycoproteinasanearlybiomarkerofdiabeticnephropathyintype2diabetesmellituspatients AT usmankauser zincalpha2glycoproteinasanearlybiomarkerofdiabeticnephropathyintype2diabetesmellituspatients AT bhosalevivek zincalpha2glycoproteinasanearlybiomarkerofdiabeticnephropathyintype2diabetesmellituspatients AT kumarsatish zincalpha2glycoproteinasanearlybiomarkerofdiabeticnephropathyintype2diabetesmellituspatients AT sharmasharad zincalpha2glycoproteinasanearlybiomarkerofdiabeticnephropathyintype2diabetesmellituspatients |